Table 1.
RBD-ACE2 interface (0 ns) |
RBD-ACE2 interface (20 ns) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Virus | RBD | ACE2 | Bond | Ekcal/mol | Dist Å | Atom | RBD | ACE2 | Bond | Ekcal/mol | Dist Å | Atom |
SARS-CoV | Arg426 | Glu329 | IH | −35.88 | 2.99 | – | Tyr481 | Lys353 | H | −9.80 | 2.89 | b- |
Gly482 | Lys353 | H | −7.20 | 2.80 | b- | Tyr436 | Asp38 | H | −5.80 | 2.75 | – | |
Tyr491 | Glu37 | H | −4.90 | 2.56 | – | Gly488 | Gly354 | H | −4.00 | 2.80 | bb | |
Tyr436 | Asp38 | H | −3.70 | 2.53 | – | Thr486 | Asn330 | H | −3.40 | 2.83 | b- | |
Asp463 | Ser19 | I | −1.49 | 3.61 | -b | Asp463 | Gln24 | H | −2.60 | 2.78 | – | |
Asn479 | Glu35 | H | −1.30 | 3.18 | – | Thr486 | Asp355 | H | −1.70 | 2.60 | – | |
Thr486 | Tyr41 | H | −1.20 | 2.99 | – | Tyr491 | Gly354 | A | −0.70 | 3.86 | -b | |
Asn473 | Gln24 | H | −1.00 | 2.89 | – | |||||||
SARS-CoV-2 | Lys417 | Asp30 | IH | −30.83 | 2.71 | – | Gln493 | Lys31 | H | −11.60 | 2.85 | – |
Tyr505 | Glu37 | H | −4.60 | 2.57 | – | Tyr449 | Asp38 | H | −2.80 | 2.58 | – | |
Gly502 | Lys353 | H | −3.60 | 3.10 | bb | Asn501 | Lys353 | H | −2.80 | 3.05 | b- | |
Gln498 | Lys353 | H | −2.90 | 3.00 | – | Gln474 | Gln24 | H | −2.70 | 2.78 | – | |
Gln506 | Gln325 | H | −2.60 | 2.82 | – | Asn487 | Gln24 | H | −2.40 | 2.85 | – | |
Asn487 | Gln325 | H | −1.60 | 2.80 | – | Gln498 | Lys353 | H | −1.60 | 3.03 | – | |
Gln493 | His34 | H | −0.50 | 3.07 | – | Thr500 | Lys353 | H | −1.40 | 2.71 | b- | |
Tyr489 | Phe28 | A | −0.60 | 3.75 | b- | |||||||
Gln498 | Tyr41 | A | −0.60 | 4.52 | – |
VH, variable heavy chain; VL, variable light chains; H, hydrogen bond; A, aromatic bond; I, ionic (electrostatic) bond; bb, backbone atoms.